Tender offer by Sanofi to acquire Ablynx



Sanofi’s offer to acquire Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies®

Belgian Offer Documents

Prospectus and Response Memorandum

Summary of the Prospectus

Acceptance and Withdrawal Forms

Placard

U.S. Offer Documents

Press releases

IR conference call